GPX4 and cancer: An elegant study showed that intracellular fumarate aggregation led to the succination of GPX4 at cysteine 93 (mono- and di-succination), which significantly reduced the enzymatic activity of GPX4 and sensitized cancer cells to FINs (Kerins et al., 2018).